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Comments on "Why Not Use
It All?"
The recent editorial by George Lucier (1)
mischaracterizes the two key aspects ofthe
Society of Toxicology (SOT)-European
Society of Toxicology (EUROTOX)
debate, which was a part ofthe program of
the March 1999 SOT Annual Meeting
held in New Orleans, Louisiana. First, the
debaters represented neither an SOT
motion nor a EUROTOX motion, i.e., this
is not a situation where the two societies
have taken an official position on an issue.
Second, the debate was not intended to
persuade the audience to simply accept one
side and jettison the data presented by the
other side. The SOT-EUROTOX debate
provides a public forum for airing different
viewpoints and differences in interpretation
of data surrounding a scientific issue. It is
framed deliberately in a provocative fashion
to stimulate an open, thorough discussion.
This type ofdiscussion facilitates introspec-
tion and leads to an enhanced understand-
ing ofthe issue at hand.
The particular debate in question
focused upon the following hypothetical
motion: "The Results of Mechanistic
Toxicity Studies Should Supersede
Ambiguous Epidemiological Data." This
debate was a part ofan annual cooperative
activity between two of the largest profes-
sional organizations of toxicologists in the
world: the SOT and EUROTOX. A topic
chosen jointly by the program committee
of each society is debated at each society's
annual meeting, the SOT meeting in
March and the EUROTOX meeting in
June. The two program committees select
a member oftheir respective society to par-
ticipate in the debate, and the same indi-
viduals debate the issue in the United
States and in Europe. In addition to select-
ing a new topic and new debaters each
year, the "side" that each society takes
changes yearly, i.e., in even-numbered
years EUROTOX speaks for the motion
and SOT speaks against it, whereas the
SOT speaks for the motion and EURO-
TOX against it in odd-number years.
Importantly, the topic does not represent
an official position of either society.
Rather, a considered extreme "pro" and
"con" side of the issue is set initially to
force each side to marshal their best ratio-
nale. Furthermore, substantial time for
audience participation is an integral com-
ponent ofthe program. Over the years we
have learned that this format facilitates an
open discussion that entails the presenta-
tion of a full range of views leading to a
more thorough understanding of the issue
at hand. Often an individual debater may
speak to an issue in which he or she has an
extensive record of publication; however,
this is not always the case. The prime
objective is to select debaters who will
develop strong arguments for the side they
are taking in a fashion analogous to an
attorney making the best argument for his
or her client.
Contrary to Lucier's editorial (1), this
format not only permits, but indeed
demands, full consideration of all relevant
data sets. The scientific expertise of the
chosen debaters plus the public nature of
the debate, combined with ample time for
both questions and comments from the
audience, ensures that this occurs. It is not
a simple case of choosing between two
opposite poles. Experience has demonstrat-
ed the scientific value of the debate. It
serves to enhance critical, constructive
thinking concerning the issue at hand.
Typically, this session draws a packed
room and, judging by the attentiveness of
the audience and their enthusiastic partici-
pation in the discussion, it is a highly val-
ued component ofour annual meeting.
We welcome more open dialog on the
value ofthis and other specific components
of the SOT annual meeting program,
which is intended to provide an interna-
tional forum for discussion of important
and sometimes controversial issues related
to the science oftoxicology.
Jay I. Goodman
DanielAcosta,Jr.
SocietyofToxicology
Reston, Virginia
E-mail: goodman3@pilot.msu.edu
REFERENCES AND NOTES
1. Lucier GW. Why not use it all? [Editorial]. Environ
Health Perspect 107:A232-A233 (1999).
"Why Not Use It All?":
Another View
I join enthusiastically in Lucier'swell crafted
editorial argument (1) that full assessment
of the carcinogenic potential of chemical
compounds requires examination of epi-
demiologic, toxicologic, and mechanistic
data. To ignore information from any of
these three sources would be wasteful,
short-sighted, and not in the best interests
ofprotecting public health.
There is, however, afourth dimension of
carcinogenic risk assessment that has not to
date received adequate consideration. This is
the developmental dimension. The young of
all mammalian species have exposures and
vulnerabilities to chemical carcinogens that
are qualitatively and quantitatively different
from those ofadults. The special susceptibil-
ities of human babies were examined in
detail in the 1993 National Academy of
Sciences report Pesticides in the Diets of
InfantsandChildren (2).
The EPA Guidelines on Carcinogenic
Risk Assessment, on which Lucier com-
ments in his editorial (1), pay only scant
attention to developmental biology. The
current draft of these guidelines continues
to embody the outmoded fiction that the
entire American population can be repre-
sented by an adult white male who weighs
70 kg. Until our national policy on car-
cinogen risk assessment moves beyond this
limiting assumption and begins to require
explicit consideration of pediatric expo-
sures and risks, there will be little incentive
for researchers to explore pathways of
exposure, patterns of disease, or mecha-
nisms of carcinogenesis in the young. We
are not yet usingall ofthe data.
PhilipJ. drigan
Community & Preventive Medicine
Mount Sinai School ofMedicine
NewYork, NewYork
E-mail: phil.landrigan@mountsinai.org
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Air Toxics Concentrations of
Methyl Chloride
On behalfofthe Methyl Chloride Industry
Association (MCIA; which comprises the
following domestic producers of methyl
chloride: Dow Chemical Company, Dow
Corning Corporation, General Electric
Company, and Vulcan Materials
Company), I would like to alert you to cer-
tain incorrect statements concerning methyl
chloride contained in "Public Health
Implications of 1990 Air Toxics
Concentrations across the United States"
(1). In this letter, I will briefly summarize
these incorrect statements and provide a
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more detailed explanation of the basis for
MCIA's position.
Woodruff et al. (1) incorrectly suggest
that industrial air emissions ofmethyl chlo-
ride present a significant health risk. On the
basis of 1990 data for the Toxics Release
Inventory (TRI) and the Cumulative
Exposure Project (CEP), Woofruff et al.
purport to identify listed hazardous air pol-
lutants (HAPs) that are present in the envi-
ronment above levels of concern based on
cancer and noncancer effects. The authors
further state that methyl chloride is one of
eight pollutants identified as having "mod-
eled concentrations exceeding the bench-
mark concentrations for cancer in 100% of
the census tracts" (1).
These statements are inaccurate for the
following reasons. First, methyl chloride air
emissions and resulting concentrations
should not be compared to a cancer health
benchmark because available data are not
sufficient to condude that methyl chloride
poses a human cancer hazard. Methyl chlo-
ride has been classified by the U.S.
Environmental Protection Agency (U.S.
EPA) as only a Group C possible human
carcinogen (2); this is based on no human
data and insufficient animal data. Further,
the International Agency for Research on
Cancer (IARC) (3) found that the evidence
of carcinogenicity of methyl chloride to
humans and to animals is inadequate; there-
fore, IARC classifies methyl chloride in
Group 3 (not classifiable). A U.S. EPA
Scientific Peer Review Panel (4), convened
for a rulemaking proceeding under 112(g) of
the Clean Air Act, agreed that compounds
classified as Group C (possible) carcinogens
should not be grouped with "known" and
"probable" human carcinogens. The avail-
able data simply are not sufficient to justify
evaluating or classifying methyl chloride
based on aperceived cancerhazard.
Second, when background concentra-
tions from natural sources are removed
from the analysis, methyl chloride emissions
do not exceed benchmark levels in 100% of
the census tracts. Perhaps up to 99% of
ambient air concentrations ofmethyl chlo-
ride are due to releases from natural sources,
rather than releases from manufacturing
and use (5). Although in their Table 2
Woodruff et al. (1) acknowledge that the
alleged exceedances for methyl chloride are
due almost entirely to background concen-
trations, rather than man-made sources,
they nevertheless purport to identify "HAPs
representing the highest potential health
risks" with the idea that
Future regulatory and scientific activities can
begin to focus on these pollutants to address and
further evaluate their public health significance.
Given the almost insignificant amount of
methyl chloride emissions from industrial
sources, efforts to reduce methyl chloride
emissions from industrial sources will not
meaningfully reduce ambient concentra-
tions of methyl chloride. Woodruff et al.
misleadingly suggest otherwise.
Woodruff et al. (1) also misleadingly
suggest that the CEP represents the U.S.
EPA's final analysis. This is not correct.
The CEP is an analysis performed by the
U.S. EPA that compared modeled ambient
air concentrations ofHAPs in urban census
tracts to chronic health effects benchmarks.
HAPs were ranked according to the num-
ber of urban census tracts in which the
modeled concentration was above the
health benchmark. Much of the needed
health effects information was previously
compiled for the U.S. EPA's proposed rule
making under Section 112(g) ofthe Clean
Air Act Amendments of 1990. In the
112(g) proposal, the U.S. EPA proposed a
relative hazard ranking of all HAPs.
However, this rule making was never final-
ized and the U.S. EPA never responded to
public comments submitted or to the views
expressed by the Scientific Peer Review
Panel concerning the inappropriateness of
classifying Group C carcinogens with
Group A and Group B carcinogens.
Because the analysis and conclusions con-
tained in the CEP were never subject to
peer review, it is therefore not a reliable
source ofinformation, nor does it represent
the U.S. EPA's final analysis ofthe data.
The editors of EHP have an obligation
to ensure that the statements contained in
its publications are factually accurate and
not misleading. This obligation is para-
mount, particularly when a paper is drafted
by a U.S. EPA staff scientist and therefore
has the potential to be mistakenlyviewed by
readers as an official U.S. EPA position.
The misleading statements included in the
paper are ofparticular concern because they
have been mistakenly relied upon by the
public and other publications. For example,
Rachel's Environment & Health Weekly (6)
appears to have relied on the EHPpaper as
the basis for a statement that
EPA ... published a report in 1998 saying that
100% ofthe outdoor air in the continental U.S.
is contaminated with eight cancer-causing indus-
trial chemicals at levels that exceed EPA's
"benchmark" safetystandards.
The paper further identified methyl chloride
as a "carcinogen" that is "known to cause
cancer." Woodruff et al. (1) is cited as the
reference for these misleading statements.
We request that such misleading infor-
mation not be published again in subsequent
papers appearing in EHPand that this letter
be published to provide the public with a
more accurate presentation ofthe facts con-
cerning methyl chloride. Ifyou have ques-
tions concernig these comments or require
furtherinformation, please contact me.
Gene R. Browning
General Electric Co.
Waterford, NewYork
E-mail: gene.browning@gepex.ge.com
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Air Toxic Concentrations:
Response
We appreciate Browning's interest in our
paper "Public Health Implications of 1990
Air Toxics Concentrations across the
United States" published in the May 1998
issue of EHP (1). In this paper we com-
pared estimated concentrations of 148 air
toxics, derived from dispersion modeling of
air toxics emissions, to previously defined
benchmarks for cancer and noncancer
effects.
As stated in the paper, the goal of the
analysis was to provide a relatively compre-
hensive assessment of the potential public
health impacts of air toxics (referred to in
the Clean Air Act as "hazardous air pollu-
tants" or HAPs) based on available infor-
mation. To conduct this analysis, we used
emissions data from stationary and mobile
sources in an atmospheric dispersion model
to estimate 1990 outdoor concentrations of
148 HAPs for every census tract in the con-
tiguous United States. For many HAPs, the
estimated concentrations also included a
background concentration, which repre-
sents the impacts of long-range transport,
resuspension of historical emissions, and
nonanthropogenic sources, that would be
present without local anthropogenic 1990
emissions. Background concentrations were
based on measurements taken in locations
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